Precise measurement. Clear evaluation. Digital networking. With VR Ocu.Motion, Talkingeyes presents state-of-the-art VR technology for objective orthoptic measurements. With Orthovision CONNECT, opticians get secure cloud access to their findings—including optional AI interpretation.
Talkingeyes & More GmbH, based in Erlangen, Germany, has been developing innovative medical devices and digital solutions for optometry and ophthalmology since 2007. The company combines virtual reality technology, telemedicine, and AI-supported evaluation to make optometric and ophthalmological analyses more efficient and easier to understand.
With patented technologies (EU Patent: EP 3 287 074 B1-"METHOD FOR DETECTING THE CEREBRAL COGNITION TIME AND DEVICE FOR MONITORING OF CEREBRAL COGNITION TIME; US Patent: United States Patent(10)Patent No.:US 11,653,864 B2 METHOD AND DEVICE FOR QUANTITATIVELY DETECTING THE FUSION CAPACITY IN CONJUGATE EYE MOVEMENTS), Talkingeyes offers objective measurement of eye motility and fusion capacity. Key innovations include VR Ocu.Motion, a system for oculomotor analysis using virtual reality, and Orthovision CONNECT, a digital platform for opticians with cloud access, findings management, and optional AI support from Dr. Neurovis.
In addition, Talkingeyes develops products such as the VR Fusion Trainer, SmartTonoTracker®, and MedStage®, which are used in optometry, clinics, and research.
The company's goal is to combine state-of-the-art technology with practical applications—for objective measurement data, reproducible results, and secure, digital collaboration between opticians, specialists, and patients.
